Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 71162 record(s)

Req # A-2024-000252

The cover letter which accompanied the initial filing of the Abbreviated New Drug Submission (ANDS) for Aripiprazole which was accepted into review in April 2024 and subsequently, included in the list of Generic submissions under review dated 2024-…

Organization: Health Canada

14 page(s)
August 2024

Req # A-2024-000258

The cover letter which accompanied the initial filing of the Abbreviated New Drug Submission (ANDS) for Tolvaptan which was accepted into review in November 2023 and, is included in the list of Generic submissions under review dated 2024-05-23 and…

Organization: Health Canada

34 page(s)
August 2024

Req # A-2024-000265

The most recent draft version and any existing feedback pertaining to the performance measurement evaluation for ethylene oxide, mentioned at this Uniform Resource Locator (URL) for greater clarity: https://www.canada.ca/en/health-canada/services/…

Organization: Health Canada

35 page(s)
August 2024

Req # A-2024-000398

Concerning the Exemptions Division, Office of Controlled Substances / Controlled Substances and Cannabis Branch, Health Canada / Government of Canada: The number of active requests for Section 56 Religious Exemptions currently being processed or…

Organization: Health Canada

25 page(s)
August 2024

Req # A-2024-000403

The following section of the Electronic Common Technical Document (eCTD) Modules for the CAMBIA® New Drug Submission denoted by Submission Control No. 178225: Section 5.3.1.2.

Organization: Health Canada

0 page(s)
August 2024

Req # A-2024-000404

The following sections of the Electronic Common Technical Document (eCTD) Modules for CAMBIA® New Drug Submission denoted by Submission Control Number 178225: Section 2.7.1. Section 2.7.6. Section 5.2. Section 5.3.1.1. Section 5.3.1.2. Section 5.3.…

Organization: Health Canada

0 page(s)
August 2024

Req # A-2024-000405

The following section of the Electronic Common Technical Document (eCTD) Modules for the CAMBIA® New Drug Submissions denoted by Submission Control Nos. 215350 and 253454: Section 5.3.1.2.

Organization: Health Canada

0 page(s)
August 2024

Req # A-2024-000406

Provide the following sections of the Electronic Common Technical Document (eCTD) Modules for the CAMBIA® New Drug Submissions denoted by Submission Control Numbers 215350 and 253454: Section 2.7.1, Section 2.7.6, Section 5.2, Section 5.3.1.1,…

Organization: Health Canada

0 page(s)
August 2024

Req # A-2024-000416

The amount spent, per year, for art costs by your department/agency from January 1, 2016, to July 4, 2024.

Organization: Health Canada

100 page(s)
August 2024

Req # A-2024-000435

The number of advertised VS non-advertised appointments for positions held by individuals in the Comptrollership (CT)-Financial Management (FIN), CT-Internal Audit (IAU) and CT-External Audit (EAV) classifications at Health Canada from April 1st,…

Organization: Health Canada

0 page(s)
August 2024
Date modified: